JLCAX
Price
$23.83
Change
+$0.16 (+0.68%)
Updated
Sep 11 closing price
Net Assets
3.66B
VFFSX
Price
$375.42
Change
+$3.22 (+0.87%)
Updated
Sep 11 closing price
Net Assets
1.76T
Interact to see
Advertisement

JLCAX vs VFFSX

JLCAX vs VFFSX Comparison Chart in %
View a ticker or compare two or three
VS
JLCAX vs. VFFSX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLCAX is a Buy and VFFSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFFSX has more cash in the bank: 1.76T vs. JLCAX (3.66B). VFFSX pays higher dividends than JLCAX: VFFSX (1.05) vs JLCAX (0.00). JLCAX was incepted earlier than VFFSX: JLCAX (21 years) vs VFFSX (10 years). JLCAX (1.94) is less costly to investors than VFFSX (0.01). JLCAX is a more actively managed with annual turnover of: 100.00 vs. VFFSX (2.00). JLCAX has a lower initial minimum investment than VFFSX: JLCAX (1000) vs VFFSX (5000000000). VFFSX annual gain was more profitable for investors over the last year : 15.26 vs. JLCAX (6.81). VFFSX return over 5 years is better than : 70.49 vs. JLCAX (-14.60).
JLCAXVFFSXJLCAX / VFFSX
Total Expense Ratio1.640.0116,400%
Annual Report Gross Expense Ratio1.940.0119,400%
Fund Existence21 years10 years-
Gain YTD6.91111.12162%
Front Load5%N/A-
Min. Initial Investment100050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets3.66B1.76T0%
Annual Yield % from dividends0.001.05-
Returns for 1 year6.8115.2645%
Returns for 3 years37.6370.3354%
Returns for 5 years-14.6070.49-21%
Returns for 10 years-11.93258.63-5%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARCT14.730.75
+5.36%
Arcturus Therapeutics Holdings
LFUS432.3018.88
+4.57%
Littelfuse
INKT12.200.07
+0.58%
MiNK Therapeutics Inc
MMTXU10.25N/A
N/A
Miluna Acquisition Corp
AUPH16.10-0.01
-0.06%
Aurinia Pharmaceuticals